Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders

Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders

The present document represents the position of Swiss health-care associations, clinical and research centers, research-supporting foundations, and the association Alzheimer Switzerland regarding the care of persons with dementia and Alzheimer’s disease. We claim that dementia is not part of normal...

Full description

Bibliographic Details
Main Authors: Giovanni B Frisoni, Jean-Marie Annoni, Stefanie Becker, Tim Brockmann, Markus Buerge, Jean-François Démonet, Dan Georgescu, Anton Gietl, Ulrich Hemmeter, Stefan Klöppel, Thomas Leyhe, Andreas U Monsch, Franco Rogantini, Delphine Roulet Schwab, Egemen Savaskan, Karl Schaller, Armin von Gunten, Gabriel Gold
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Clinical and Translational Neuroscience
Subjects:
dementia
Alzheimer’s
cholinesterase inhibitors
Online Access:https://www.mdpi.com/2514-183X/5/2/14

Internet

https://www.mdpi.com/2514-183X/5/2/14

Similar Items